Healthcare Sector Stocks
The Healthcare sector has a total of 1063 stocks, with a combined market cap of $8.31 trillion, total revenue of $4.52 trillion and a weighted average PE ratio of 40.12.
Market Cap
8.31T
Revenue
4.52T
Profits
207.12B
PE Ratio
40.12
Profit Margin
4.59%
Dividend Yield
0.44%
1063 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 840.66B | -1.65% | 1,958,901 | 65.18B |
| 2 | JNJ | Johnson & Johnson | 574.36B | -1.18% | 7,354,177 | 94.19B |
| 3 | ABBV | AbbVie Inc. | 367.80B | -2.10% | 4,632,491 | 61.16B |
| 4 | AZN | AstraZeneca PLC | 318.20B | -0.47% | 1,566,766 | 58.74B |
| 5 | MRK | Merck & Co., Inc. | 299.89B | -1.03% | 9,706,719 | 65.01B |
| 6 | NVS | Novartis AG | 294.69B | -0.65% | 997,007 | 56.67B |
| 7 | UNH | UnitedHealth Group Incorporated | 276.23B | -0.84% | 5,212,673 | 447.57B |
| 8 | AMGN | Amgen Inc. | 189.44B | -1.29% | 2,257,411 | 36.75B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 184.37B | -0.87% | 1,308,721 | 44.56B |
| 10 | ABT | Abbott Laboratories | 174.69B | -2.36% | 11,944,617 | 44.33B |
| 11 | GILD | Gilead Sciences, Inc. | 172.52B | -2.18% | 4,418,216 | 29.44B |
| 12 | NVO | Novo Nordisk A/S | 167.68B | 0.21% | 11,397,901 | 48.59B |
| 13 | ISRG | Intuitive Surgical, Inc. | 160.05B | -0.95% | 1,466,024 | 10.06B |
| 14 | PFE | Pfizer Inc. | 153.13B | -1.10% | 27,880,096 | 62.58B |
| 15 | DHR | Danaher Corporation | 134.19B | -1.75% | 3,188,786 | 24.57B |
| 16 | SYK | Stryker Corporation | 129.79B | - | 1,733,722 | 25.12B |
| 17 | BMY | Bristol-Myers Squibb Company | 119.69B | -1.43% | 8,060,093 | 48.19B |
| 18 | GSK | GSK plc | 117.14B | -0.26% | 4,407,798 | 43.97B |
| 19 | SNY | Sanofi | 113.67B | -0.68% | 2,227,792 | 54.85B |
| 20 | MDT | Medtronic plc | 111.97B | -0.80% | 8,279,587 | 35.48B |
| 21 | VRTX | Vertex Pharmaceuticals Incorporated | 110.97B | -2.35% | 985,766 | 12.00B |
| 22 | HCA | HCA Healthcare, Inc. | 110.77B | -2.31% | 733,819 | 75.60B |
| 23 | MCK | McKesson Corporation | 106.03B | -0.90% | 615,170 | 397.96B |
| 24 | CVS | CVS Health Corporation | 101.67B | 0.62% | 6,857,593 | 399.83B |
| 25 | BSX | Boston Scientific Corporation | 91.83B | 0.83% | 14,773,893 | 20.07B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 76.85B | -2.47% | 751,395 | 14.34B |
| 27 | CI | The Cigna Group | 71.52B | -2.59% | 906,717 | 274.90B |
| 28 | ELV | Elevance Health, Inc. | 68.43B | -1.69% | 1,050,248 | 199.13B |
| 29 | COR | Cencora, Inc. | 62.41B | -0.51% | 1,028,762 | 325.78B |
| 30 | MDLN | Medline Inc. | 59.90B | -0.20% | 4,549,602 | 28.43B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 56.91B | -2.06% | 2,684,710 | 28.48B |
| 32 | CAH | Cardinal Health, Inc. | 50.72B | -0.13% | 1,292,182 | 244.67B |
| 33 | ARGX | argenx SE | 49.79B | -0.11% | 312,160 | 4.24B |
| 34 | ZTS | Zoetis Inc. | 49.56B | -1.78% | 2,409,197 | 9.47B |
| 35 | EW | Edwards Lifesciences Corporation | 44.90B | -1.62% | 4,946,245 | 6.07B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 44.72B | -3.72% | 498,547 | 4.30B |
| 37 | BDX | Becton, Dickinson and Company | 43.91B | -0.80% | 2,051,567 | 21.92B |
| 38 | HLN | Haleon plc | 43.73B | -0.47% | 4,880,868 | 14.85B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 42.72B | 0.26% | 698,550 | 3.71B |
| 40 | ALC | Alcon Inc. | 38.08B | 0.79% | 1,455,855 | 10.40B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 35.89B | -0.45% | 4,276,636 | 17.26B |
| 42 | ONC | BeOne Medicines AG | 34.34B | -1.20% | 134,387 | 5.34B |
| 43 | INSM | Insmed Incorporated | 33.42B | -3.00% | 1,826,853 | 606.42M |
| 44 | GEHC | GE HealthCare Technologies Inc. | 33.39B | 0.37% | 2,691,698 | 20.63B |
| 45 | RMD | ResMed Inc. | 33.20B | 0.39% | 843,983 | 5.40B |
| 46 | A | Agilent Technologies, Inc. | 32.52B | -0.29% | 1,033,219 | 7.07B |
| 47 | WAT | Waters Corporation | 31.41B | 0.74% | 857,036 | 3.17B |
| 48 | IQV | IQVIA Holdings Inc. | 28.09B | -0.97% | 1,454,514 | 16.31B |
| 49 | RPRX | Royalty Pharma plc | 27.63B | -0.83% | 2,370,085 | 2.38B |
| 50 | NTRA | Natera, Inc. | 27.36B | -4.91% | 2,871,327 | 2.31B |
| 51 | PHG | Koninklijke Philips N.V. | 27.10B | 0.64% | 849,006 | 20.94B |
| 52 | MTD | Mettler-Toledo International Inc. | 26.83B | -0.75% | 120,485 | 4.03B |
| 53 | BIIB | Biogen Inc. | 25.38B | -2.34% | 1,477,502 | 9.89B |
| 54 | UTHR | United Therapeutics Corporation | 25.06B | -0.53% | 443,227 | 3.18B |
| 55 | VEEV | Veeva Systems Inc. | 24.73B | -3.60% | 3,959,284 | 3.20B |
| 56 | DXCM | DexCom, Inc. | 24.64B | -2.53% | 2,107,136 | 4.66B |
| 57 | BNTX | BioNTech SE | 24.15B | 3.83% | 1,000,721 | 3.37B |
| 58 | HUM | Humana Inc. | 23.07B | -2.62% | 1,371,307 | 129.66B |
| 59 | STE | STERIS plc | 21.83B | -0.52% | 450,676 | 5.83B |
| 60 | LH | Labcorp Holdings Inc. | 21.50B | -4.51% | 796,564 | 13.95B |
| 61 | DGX | Quest Diagnostics Incorporated | 21.20B | -3.19% | 1,044,090 | 11.04B |
| 62 | MRNA | Moderna, Inc. | 20.21B | -0.62% | 6,275,967 | 1.94B |
| 63 | ROIV | Roivant Sciences Ltd. | 20.19B | -0.95% | 3,126,934 | 13.31M |
| 64 | INCY | Incyte Corporation | 19.12B | -0.92% | 1,146,786 | 5.14B |
| 65 | RVMD | Revolution Medicines, Inc. | 19.11B | 0.22% | 1,984,800 | - |
| 66 | ILMN | Illumina, Inc. | 18.49B | -2.22% | 1,805,422 | 4.34B |
| 67 | WST | West Pharmaceutical Services, Inc. | 18.48B | -0.77% | 656,795 | 3.07B |
| 68 | CNC | Centene Corporation | 18.34B | -0.67% | 5,145,033 | 176.15B |
| 69 | ZBH | Zimmer Biomet Holdings, Inc. | 18.03B | 0.10% | 1,769,171 | 8.23B |
| 70 | GMAB | Genmab A/S | 17.25B | -0.11% | 1,472,483 | 3.72B |
| 71 | THC | Tenet Healthcare Corporation | 16.98B | -3.28% | 1,460,854 | 21.31B |
| 72 | VTRS | Viatris Inc. | 15.68B | -1.03% | 6,538,924 | 14.30B |
| 73 | SMMT | Summit Therapeutics Inc. | 15.25B | 1.86% | 2,520,029 | - |
| 74 | ASND | Ascendis Pharma A/S | 14.78B | -1.01% | 687,205 | 845.52M |
| 75 | BBIO | BridgeBio Pharma, Inc. | 14.46B | -1.23% | 1,075,821 | 502.08M |
| 76 | SNN | Smith & Nephew plc | 14.34B | 1.06% | 650,112 | 6.16B |
| 77 | RGC | Regencell Bioscience Holdings Limited | 14.25B | 2.31% | 73,217 | - |
| 78 | MEDP | Medpace Holdings, Inc. | 14.09B | -1.59% | 192,099 | 2.53B |
| 79 | COO | The Cooper Companies, Inc. | 13.89B | -0.35% | 1,471,732 | 4.15B |
| 80 | PODD | Insulet Corporation | 13.64B | -1.25% | 729,783 | 2.71B |
| 81 | PEN | Penumbra, Inc. | 12.97B | 0.08% | 438,734 | 1.40B |
| 82 | NBIX | Neurocrine Biosciences, Inc. | 12.94B | -2.09% | 806,357 | 2.86B |
| 83 | FMS | Fresenius Medical Care AG | 12.80B | 0.08% | 267,955 | 23.05B |
| 84 | IONS | Ionis Pharmaceuticals, Inc. | 12.42B | -1.65% | 1,581,559 | 943.71M |
| 85 | ALGN | Align Technology, Inc. | 12.40B | -0.80% | 784,902 | 4.03B |
| 86 | GMED | Globus Medical, Inc. | 12.23B | -1.07% | 1,028,040 | 2.94B |
| 87 | JAZZ | Jazz Pharmaceuticals plc | 11.96B | -1.99% | 904,085 | 4.27B |
| 88 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.92B | -0.89% | 294,610 | 958.40M |
| 89 | ENSG | The Ensign Group, Inc. | 11.63B | -1.26% | 253,498 | 5.06B |
| 90 | ELAN | Elanco Animal Health Incorporated | 11.50B | -1.41% | 3,442,128 | 4.72B |
| 91 | EXEL | Exelixis, Inc. | 11.50B | -2.51% | 2,945,425 | 2.32B |
| 92 | SOLV | Solventum Corporation | 11.41B | -0.59% | 1,124,964 | 8.33B |
| 93 | UHS | Universal Health Services, Inc. | 11.03B | -3.78% | 464,090 | 17.36B |
| 94 | RDY | Dr. Reddy's Laboratories Limited | 11.03B | 0.38% | 1,622,490 | 3.85B |
| 95 | EHC | Encompass Health Corporation | 10.66B | -1.00% | 795,575 | 5.94B |
| 96 | BMRN | BioMarin Pharmaceutical Inc. | 10.49B | -3.14% | 1,540,870 | 3.22B |
| 97 | GH | Guardant Health, Inc. | 10.31B | -9.83% | 6,406,621 | 982.02M |
| 98 | RVTY | Revvity, Inc. | 10.04B | -0.74% | 658,342 | 2.86B |
| 99 | ABVX | ABIVAX Société Anonyme | 10.03B | 0.36% | 998,599 | 5.37M |
| 100 | DVA | DaVita Inc. | 10.02B | -0.42% | 456,063 | 13.64B |
| 101 | MASI | Masimo Corporation | 9.31B | -0.01% | 494,478 | 1.53B |
| 102 | BTSG | BrightSpring Health Services, Inc. | 9.25B | -1.28% | 1,413,566 | 12.91B |
| 103 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.12B | -1.65% | 1,670,522 | 1.09B |
| 104 | AXSM | Axsome Therapeutics, Inc. | 9.11B | -0.44% | 560,243 | 638.50M |
| 105 | BAX | Baxter International Inc. | 8.85B | -0.87% | 3,536,517 | 11.24B |
| 106 | PRAX | Praxis Precision Medicines, Inc. | 8.80B | -1.28% | 254,069 | 7.46M |
| 107 | PCVX | Vaxcyte, Inc. | 8.76B | -1.31% | 863,474 | - |
| 108 | TECH | Bio-Techne Corporation | 8.69B | -0.05% | 1,196,961 | 1.22B |
| 109 | CRL | Charles River Laboratories International, Inc. | 8.65B | 0.06% | 487,926 | 4.02B |
| 110 | HSIC | Henry Schein, Inc. | 8.65B | -0.37% | 874,158 | 13.18B |
| 111 | QGEN | Qiagen N.V. | 8.46B | -0.29% | 1,159,736 | 2.09B |
| 112 | ATR | AptarGroup, Inc. | 8.39B | 0.08% | 407,429 | 3.78B |
| 113 | ICLR | ICON Public Limited Company | 8.16B | 0.10% | 669,617 | 8.10B |
| 114 | NUVL | Nuvalent, Inc. | 8.08B | -1.77% | 412,760 | - |
| 115 | HALO | Halozyme Therapeutics, Inc. | 8.03B | 1.10% | 999,831 | 1.40B |
| 116 | CYTK | Cytokinetics, Incorporated | 8.01B | 0.65% | 1,224,407 | 88.04M |
| 117 | TEM | Tempus AI, Inc. | 7.70B | -2.76% | 6,837,737 | 1.27B |
| 118 | KRYS | Krystal Biotech, Inc. | 7.62B | 0.26% | 162,513 | 389.13M |
| 119 | MOH | Molina Healthcare, Inc. | 7.60B | 0.57% | 759,004 | 43.56B |
| 120 | BIO | Bio-Rad Laboratories, Inc. | 7.54B | 0.63% | 276,583 | 2.58B |
| 121 | IBRX | ImmunityBio, Inc. | 7.52B | -2.67% | 14,361,211 | 113.29M |
| 122 | KYMR | Kymera Therapeutics, Inc. | 6.94B | -2.63% | 399,731 | 39.21M |
| 123 | BLTE | Belite Bio, Inc | 6.80B | -4.64% | 198,927 | - |
| 124 | RGEN | Repligen Corporation | 6.77B | 0.27% | 541,115 | 738.26M |
| 125 | GKOS | Glaukos Corporation | 6.76B | -2.55% | 522,047 | 507.44M |
| 126 | ACLX | Arcellx, Inc. | 6.74B | 0.03% | 789,736 | 22.29M |
| 127 | HQY | HealthEquity, Inc. | 6.59B | -7.41% | 1,131,878 | 1.31B |
| 128 | GRFS | Grifols, S.A. | 6.55B | 1.99% | 516,903 | 8.83B |
| 129 | APGE | Apogee Therapeutics, Inc. | 6.37B | -0.29% | 397,192 | - |
| 130 | PTGX | Protagonist Therapeutics, Inc. | 6.31B | -5.06% | 577,206 | 46.02M |
| 131 | CNTA | Centessa Pharmaceuticals plc | 6.11B | -0.70% | 1,262,501 | 15.00M |
| 132 | TERN | Terns Pharmaceuticals, Inc. | 6.08B | 0.13% | 4,977,712 | - |
| 133 | COGT | Cogent Biosciences, Inc. | 5.86B | -2.62% | 1,468,753 | - |
| 134 | BLCO | Bausch + Lomb Corporation | 5.84B | 0.06% | 340,472 | 5.10B |
| 135 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.76B | -2.02% | 379,088 | 189.76M |
| 136 | MIRM | Mirum Pharmaceuticals, Inc. | 5.74B | -3.79% | 722,852 | 521.31M |
| 137 | SRRK | Scholar Rock Holding Corporation | 5.74B | 1.57% | 1,186,167 | - |
| 138 | BRKR | Bruker Corporation | 5.72B | -1.03% | 1,253,604 | 3.44B |
| 139 | CGON | CG Oncology, Inc. | 5.72B | -1.25% | 1,214,887 | 4.04M |
| 140 | PTCT | PTC Therapeutics, Inc. | 5.69B | -3.05% | 587,612 | 1.73B |
| 141 | CELC | Celcuity Inc. | 5.66B | -6.02% | 625,722 | - |
| 142 | XENE | Xenon Pharmaceuticals Inc. | 5.57B | -0.32% | 655,879 | 7.50M |
| 143 | ALKS | Alkermes plc | 5.55B | -4.47% | 2,036,573 | 1.48B |
| 144 | AVTR | Avantor, Inc. | 5.34B | -0.25% | 4,591,257 | 6.55B |
| 145 | CHE | Chemed Corporation | 5.31B | -1.28% | 127,661 | 2.53B |
| 146 | PACS | PACS Group, Inc. | 5.30B | -6.17% | 666,326 | 5.29B |
| 147 | ERAS | Erasca, Inc. | 5.29B | -2.02% | 3,067,503 | - |
| 148 | LNTH | Lantheus Holdings, Inc. | 5.24B | -1.03% | 486,222 | 1.54B |
| 149 | TFX | Teleflex Incorporated | 5.23B | -1.56% | 475,826 | 1.99B |
| 150 | APLS | Apellis Pharmaceuticals, Inc. | 5.21B | 0.34% | 6,741,070 | 1.00B |
| 151 | CAI | Caris Life Sciences, Inc. | 5.10B | -5.99% | 2,720,224 | 812.03M |
| 152 | IMVT | Immunovant, Inc. | 4.99B | -4.48% | 1,212,255 | - |
| 153 | TGTX | TG Therapeutics, Inc. | 4.98B | -2.60% | 1,407,835 | 616.29M |
| 154 | CRSP | CRISPR Therapeutics AG | 4.92B | -0.97% | 871,550 | 3.51M |
| 155 | DNTH | Dianthus Therapeutics, Inc. | 4.75B | -2.06% | 481,108 | 2.04M |
| 156 | FOLD | Amicus Therapeutics, Inc. | 4.54B | -0.07% | 2,036,079 | 634.21M |
| 157 | OPCH | Option Care Health, Inc. | 4.54B | -1.59% | 1,598,720 | 5.65B |
| 158 | CORT | Corcept Therapeutics Incorporated | 4.46B | -0.80% | 843,252 | 761.41M |
| 159 | HIMS | Hims & Hers Health, Inc. | 4.43B | -1.62% | 16,052,396 | 2.35B |
| 160 | SHC | Sotera Health Company | 4.37B | 0.52% | 1,912,193 | 1.16B |
| 161 | RDNT | RadNet, Inc. | 4.30B | -1.14% | 428,094 | 2.04B |
| 162 | NVST | Envista Holdings Corporation | 4.30B | -1.05% | 1,377,992 | 2.72B |
| 163 | OSCR | Oscar Health, Inc. | 4.30B | -0.62% | 5,285,547 | 11.70B |
| 164 | ALHC | Alignment Healthcare, Inc. | 4.19B | -4.12% | 3,121,022 | 3.95B |
| 165 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.13B | -0.48% | 761,028 | 7.70M |
| 166 | WAY | Waystar Holding Corp. | 4.12B | -1.42% | 1,976,907 | 1.10B |
| 167 | LGND | Ligand Pharmaceuticals Incorporated | 4.09B | -0.35% | 277,346 | 268.09M |
| 168 | MMSI | Merit Medical Systems, Inc. | 4.06B | -0.57% | 520,848 | 1.52B |
| 169 | SYRE | Spyre Therapeutics, Inc. | 4.03B | -0.93% | 498,967 | - |
| 170 | AMRX | Amneal Pharmaceuticals, Inc. | 4.00B | -2.03% | 1,472,070 | 3.02B |
| 171 | NAMS | NewAmsterdam Pharma Company N.V. | 4.00B | -0.88% | 547,230 | 22.50M |
| 172 | VKTX | Viking Therapeutics, Inc. | 3.97B | -1.97% | 1,735,100 | - |
| 173 | TMDX | TransMedics Group, Inc. | 3.91B | 4.40% | 822,610 | 605.49M |
| 174 | MMED | Minimed Group, Inc. | 3.91B | 0.87% | 663,474 | 2.89B |
| 175 | DOCS | Doximity, Inc. | 3.89B | -0.52% | 3,635,233 | 637.78M |
| 176 | GPCR | Structure Therapeutics Inc. | 3.86B | -1.14% | 1,239,752 | - |
| 177 | BLLN | BillionToOne, Inc. | 3.73B | -1.66% | 468,483 | 305.11M |
| 178 | IRTC | iRhythm Holdings, Inc. | 3.72B | -2.47% | 305,216 | 747.14M |
| 179 | ACAD | ACADIA Pharmaceuticals Inc. | 3.71B | -3.68% | 849,255 | 1.07B |
| 180 | STVN | Stevanato Group S.p.A. | 3.69B | -1.67% | 478,223 | 1.39B |
| 181 | KNSA | Kiniksa Pharmaceuticals International, plc | 3.60B | -0.53% | 479,690 | 677.56M |
| 182 | EWTX | Edgewise Therapeutics, Inc. | 3.52B | -2.09% | 599,327 | - |
| 183 | TLX | Telix Pharmaceuticals Limited | 3.52B | 7.55% | 432,376 | 803.79M |
| 184 | LIVN | LivaNova PLC | 3.43B | -0.93% | 638,903 | 1.39B |
| 185 | LQDA | Liquidia Corporation | 3.40B | -4.39% | 1,418,614 | 158.32M |
| 186 | LEGN | Legend Biotech Corporation | 3.36B | -0.22% | 2,182,518 | 1.03B |
| 187 | BKD | Brookdale Senior Living Inc. | 3.22B | -1.60% | 3,148,638 | 3.05B |
| 188 | VERA | Vera Therapeutics, Inc. | 3.21B | 10.04% | 2,934,190 | - |
| 189 | ICUI | ICU Medical, Inc. | 3.14B | -0.12% | 264,701 | 2.23B |
| 190 | TARS | Tarsus Pharmaceuticals, Inc. | 3.09B | 0.18% | 383,800 | 451.36M |
| 191 | DYN | Dyne Therapeutics, Inc. | 3.08B | -3.51% | 1,243,829 | - |
| 192 | DNLI | Denali Therapeutics Inc. | 3.05B | -0.31% | 1,127,297 | - |
| 193 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.05B | -2.58% | 1,276,710 | 588.99M |
| 194 | ARQT | Arcutis Biotherapeutics, Inc. | 3.00B | -1.47% | 894,690 | 376.07M |
| 195 | TXG | 10x Genomics, Inc. | 2.97B | 1.17% | 1,740,820 | 642.82M |
| 196 | ORKA | Oruka Therapeutics, Inc. | 2.95B | -6.32% | 1,021,686 | - |
| 197 | TWST | Twist Bioscience Corporation | 2.94B | -1.90% | 726,750 | 391.56M |
| 198 | ALMS | Alumis Inc. | 2.93B | 0.48% | 910,667 | 24.05M |
| 199 | SUPN | Supernus Pharmaceuticals, Inc. | 2.92B | -1.59% | 445,236 | 718.95M |
| 200 | ITGR | Integer Holdings Corporation | 2.90B | -1.80% | 286,327 | 1.85B |
| 201 | TNGX | Tango Therapeutics, Inc. | 2.85B | -3.62% | 1,731,138 | 62.38M |
| 202 | CON | Concentra Group Holdings Parent, Inc. | 2.82B | -1.17% | 568,165 | 2.16B |
| 203 | PRVA | Privia Health Group, Inc. | 2.81B | -1.50% | 875,755 | 2.12B |
| 204 | RCUS | Arcus Biosciences, Inc. | 2.80B | -4.04% | 590,564 | 247.00M |
| 205 | HNGE | Hinge Health, Inc. | 2.79B | -1.58% | 980,046 | 587.86M |
| 206 | BEAM | Beam Therapeutics Inc. | 2.72B | 4.18% | 2,003,584 | 139.74M |
| 207 | SLNO | Soleno Therapeutics, Inc. | 2.72B | 0.23% | 3,501,386 | 190.41M |
| 208 | ELVN | Enliven Therapeutics, Inc. | 2.71B | -0.59% | 1,124,516 | - |
| 209 | IDYA | IDEAYA Biosciences, Inc. | 2.68B | -1.61% | 1,474,449 | 218.71M |
| 210 | PBH | Prestige Consumer Healthcare Inc. | 2.68B | -0.37% | 340,532 | 1.10B |
| 211 | TVTX | Travere Therapeutics, Inc. | 2.68B | -7.89% | 2,809,196 | 490.73M |
| 212 | RLAY | Relay Therapeutics, Inc. | 2.67B | -0.40% | 2,786,428 | 15.36M |
| 213 | NHC | National HealthCare Corporation | 2.67B | -3.37% | 114,209 | 1.52B |
| 214 | HAE | Haemonetics Corporation | 2.66B | -1.88% | 447,239 | 1.32B |
| 215 | KOD | Kodiak Sciences Inc. | 2.66B | 1.77% | 738,508 | - |
| 216 | LMAT | LeMaitre Vascular, Inc. | 2.61B | 1.69% | 171,365 | 249.60M |
| 217 | MANE | Veradermics, Incorporated | 2.57B | 14.70% | 631,967 | - |
| 218 | WRBY | Warby Parker Inc. | 2.55B | -0.57% | 1,552,603 | 871.91M |
| 219 | HCM | HUTCHMED (China) Limited | 2.55B | 0.53% | 26,285 | 548.51M |
| 220 | IRON | Disc Medicine, Inc. | 2.53B | -1.46% | 194,262 | - |
| 221 | CLDX | Celldex Therapeutics, Inc. | 2.53B | -4.10% | 696,117 | 1.55M |
| 222 | LFST | LifeStance Health Group, Inc. | 2.49B | -1.39% | 1,057,316 | 1.42B |
| 223 | GRDN | Guardian Pharmacy Services, Inc. | 2.48B | -3.69% | 350,642 | 1.45B |
| 224 | VCYT | Veracyte, Inc. | 2.47B | -0.83% | 798,425 | 517.15M |
| 225 | IMNM | Immunome, Inc. | 2.45B | -3.52% | 1,138,670 | 6.94M |
| 226 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.40B | -3.34% | 4,432,118 | 874.84M |
| 227 | ACHC | Acadia Healthcare Company, Inc. | 2.39B | -4.63% | 2,536,841 | 3.31B |
| 228 | PAHC | Phibro Animal Health Corporation | 2.35B | -2.03% | 241,621 | 1.46B |
| 229 | XRAY | DENTSPLY SIRONA Inc. | 2.34B | -1.26% | 1,886,023 | 3.68B |
| 230 | ZLAB | Zai Lab Limited | 2.33B | -0.29% | 493,363 | 460.16M |
| 231 | HTFL | HeartFlow, Inc. | 2.31B | -0.48% | 743,835 | 176.03M |
| 232 | ADMA | ADMA Biologics, Inc. | 2.31B | -2.41% | 3,878,805 | 510.17M |
| 233 | AAPG | Ascentage Pharma Group International | 2.31B | -2.13% | 623 | 82.08M |
| 234 | OGN | Organon & Co. | 2.30B | 27.79% | 39,482,356 | 6.22B |
| 235 | RARE | Ultragenyx Pharmaceutical Inc. | 2.29B | -2.55% | 1,551,091 | 673.00M |
| 236 | SRPT | Sarepta Therapeutics, Inc. | 2.22B | -4.72% | 1,993,617 | 2.20B |
| 237 | NKTR | Nektar Therapeutics | 2.22B | -0.45% | 445,758 | 55.23M |
| 238 | DAWN | Day One Biopharmaceuticals, Inc. | 2.22B | -0.05% | 1,191,863 | 158.18M |
| 239 | MLYS | Mineralys Therapeutics, Inc. | 2.19B | -2.02% | 981,964 | - |
| 240 | SNDX | Syndax Pharmaceuticals, Inc. | 2.16B | -1.29% | 912,029 | 172.35M |
| 241 | DFTX | Definium Therapeutics, Inc. | 2.15B | 0.51% | 1,436,702 | - |
| 242 | AUPH | Aurinia Pharmaceuticals Inc. | 2.10B | -1.25% | 938,318 | 283.06M |
| 243 | BHC | Bausch Health Companies Inc. | 2.08B | 3.90% | 1,698,771 | 10.27B |
| 244 | NEOG | Neogen Corporation | 2.05B | -6.18% | 4,849,509 | 870.56M |
| 245 | STOK | Stoke Therapeutics, Inc. | 2.03B | -2.33% | 358,027 | 184.42M |
| 246 | SEM | Select Medical Holdings Corporation | 2.03B | - | 1,230,165 | 5.45B |
| 247 | ANAB | AnaptysBio, Inc. | 2.02B | 2.28% | 460,117 | 234.60M |
| 248 | ADPT | Adaptive Biotechnologies Corporation | 1.97B | -4.55% | 3,309,911 | 276.98M |
| 249 | AHG | Akso Health Group | 1.96B | 1.33% | 160,167 | 14.84M |
| 250 | MESO | Mesoblast Limited | 1.94B | 3.09% | 200,067 | 65.38M |
| 251 | ZYME | Zymeworks Inc. | 1.94B | -3.77% | 532,512 | 105.97M |
| 252 | AGIO | Agios Pharmaceuticals, Inc. | 1.93B | - | 765,236 | 54.03M |
| 253 | OCUL | Ocular Therapeutix, Inc. | 1.91B | -5.48% | 3,124,454 | 51.95M |
| 254 | TYRA | Tyra Biosciences, Inc. | 1.90B | -3.90% | 875,338 | - |
| 255 | GLPG | Galapagos NV | 1.89B | -0.56% | 137,102 | 1.31B |
| 256 | GRAL | GRAIL, Inc. | 1.87B | -4.06% | 1,291,584 | 147.17M |
| 257 | AORT | Artivion, Inc. | 1.82B | 3.07% | 448,445 | 441.33M |
| 258 | PVLA | Palvella Therapeutics, Inc. | 1.82B | -2.37% | 178,027 | - |
| 259 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.81B | -5.54% | 851,340 | -665.00K |
| 260 | CAPR | Capricor Therapeutics, Inc. | 1.79B | -1.30% | 743,610 | 11.13M |
| 261 | ESTA | Establishment Labs Holdings Inc. | 1.76B | -3.01% | 354,544 | 211.08M |
| 262 | INVA | Innoviva, Inc. | 1.76B | -1.82% | 859,009 | 411.33M |
| 263 | WGS | GeneDx Holdings Corp. | 1.75B | -0.72% | 665,068 | 427.54M |
| 264 | PHVS | Pharvaris N.V. | 1.74B | -1.63% | 140,320 | - |
| 265 | MD | Pediatrix Medical Group, Inc. | 1.74B | 0.52% | 465,576 | 1.91B |
| 266 | RXRX | Recursion Pharmaceuticals, Inc. | 1.73B | -0.91% | 8,605,067 | 74.68M |
| 267 | VCEL | Vericel Corporation | 1.72B | 0.33% | 239,626 | 276.26M |
| 268 | SION | Sionna Therapeutics, Inc. | 1.70B | -2.57% | 223,104 | - |
| 269 | TRVI | Trevi Therapeutics, Inc. | 1.69B | -0.83% | 973,534 | - |
| 270 | ADUS | Addus HomeCare Corporation | 1.67B | -0.60% | 217,131 | 1.42B |
| 271 | HRMY | Harmony Biosciences Holdings, Inc. | 1.67B | -0.93% | 560,699 | 868.45M |
| 272 | AXGN | Axogen, Inc. | 1.66B | -3.21% | 632,947 | 225.21M |
| 273 | NRIX | Nurix Therapeutics, Inc. | 1.66B | -1.29% | 1,156,403 | 71.78M |
| 274 | SGRY | Surgery Partners, Inc. | 1.66B | -0.23% | 833,167 | 3.31B |
| 275 | AHCO | AdaptHealth Corp. | 1.65B | -0.41% | 644,856 | 3.24B |
| 276 | ATEC | Alphatec Holdings, Inc. | 1.65B | -1.54% | 1,626,999 | 764.16M |
| 277 | ANIP | ANI Pharmaceuticals, Inc. | 1.64B | -2.22% | 581,369 | 883.37M |
| 278 | RAPP | Rapport Therapeutics, Inc. | 1.63B | -0.15% | 166,425 | - |
| 279 | OCS | Oculis Holding AG | 1.62B | 0.40% | 133,486 | 1.51M |
| 280 | NTLA | Intellia Therapeutics, Inc. | 1.59B | -2.46% | 1,809,235 | 67.67M |
| 281 | NUVB | Nuvation Bio Inc. | 1.58B | -0.65% | 3,566,606 | 62.90M |
| 282 | IMCR | Immunocore Holdings plc | 1.57B | -2.39% | 268,469 | 400.02M |
| 283 | OMCL | Omnicell, Inc. | 1.56B | -3.02% | 325,656 | 1.18B |
| 284 | DMRA | Damora Therapeutics, Inc. | 1.56B | -3.26% | 287,217 | - |
| 285 | INSP | Inspire Medical Systems, Inc. | 1.56B | -4.71% | 1,400,126 | 911.98M |
| 286 | UFPT | UFP Technologies, Inc. | 1.55B | -1.15% | 172,088 | 602.80M |
| 287 | VRDN | Viridian Therapeutics, Inc. | 1.53B | -2.80% | 2,407,801 | 70.85M |
| 288 | IOVA | Iovance Biotherapeutics, Inc. | 1.52B | -7.73% | 44,592,905 | 263.50M |
| 289 | SNDA | Sonida Senior Living, Inc. | 1.52B | -0.06% | 711,150 | 336.39M |
| 290 | VIR | Vir Biotechnology, Inc. | 1.52B | -3.36% | 1,408,298 | 68.56M |
| 291 | ARDX | Ardelyx, Inc. | 1.52B | 0.82% | 3,478,390 | 407.32M |
| 292 | PRGO | Perrigo Company plc | 1.49B | 2.45% | 1,937,892 | 4.25B |
| 293 | MBX | MBX Biosciences, Inc. | 1.47B | -5.66% | 284,254 | - |
| 294 | PGEN | Precigen, Inc. | 1.47B | -2.58% | 2,826,265 | 9.68M |
| 295 | NBTX | Nanobiotix S.A. | 1.46B | -0.57% | 46,125 | 38.27M |
| 296 | GENB | Generate Biomedicines, Inc. | 1.45B | -1.04% | 345,915 | 31.89M |
| 297 | SVRA | Savara Inc. | 1.43B | -3.58% | 1,807,982 | - |
| 298 | ATRC | AtriCure, Inc. | 1.43B | 0.64% | 1,147,230 | 534.53M |
| 299 | ENOV | Enovis Corporation | 1.41B | 1.75% | 510,980 | 2.25B |
| 300 | OLMA | Olema Pharmaceuticals, Inc. | 1.40B | -3.25% | 1,212,335 | - |
| 301 | GLUE | Monte Rosa Therapeutics, Inc. | 1.40B | -3.16% | 711,592 | 123.67M |
| 302 | IMTX | Immatics N.V. | 1.40B | -2.16% | 203,529 | 56.67M |
| 303 | BCAX | Bicara Therapeutics Inc. | 1.38B | -3.91% | 483,571 | - |
| 304 | BHVN | Biohaven Ltd. | 1.38B | -2.34% | 1,350,167 | - |
| 305 | HCSG | Healthcare Services Group, Inc. | 1.37B | 0.83% | 526,984 | 1.84B |
| 306 | ASTH | Astrana Health, Inc. | 1.37B | -2.13% | 275,235 | 3.18B |
| 307 | AVAH | Aveanna Healthcare Holdings Inc. | 1.35B | -5.90% | 835,083 | 2.43B |
| 308 | WVE | Wave Life Sciences Ltd. | 1.35B | 0.28% | 1,865,736 | 42.73M |
| 309 | ARDT | Ardent Health, Inc. | 1.34B | -1.36% | 304,580 | 6.32B |
| 310 | HROW | Harrow, Inc. | 1.34B | -3.65% | 431,845 | 272.30M |
| 311 | ATAI | AtaiBeckley Inc. | 1.33B | -1.62% | 2,295,603 | 4.09M |
| 312 | MAZE | Maze Therapeutics, Inc. | 1.33B | -4.27% | 1,052,356 | 2.50M |
| 313 | NVAX | Novavax, Inc. | 1.32B | -4.92% | 3,450,124 | 1.12B |
| 314 | TNDM | Tandem Diabetes Care, Inc. | 1.31B | -2.54% | 926,309 | 1.01B |
| 315 | STAA | STAAR Surgical Company | 1.31B | 4.88% | 1,743,855 | 239.44M |
| 316 | PRCT | PROCEPT BioRobotics Corporation | 1.31B | -0.30% | 1,129,741 | 308.05M |
| 317 | TSHA | Taysha Gene Therapies, Inc. | 1.29B | -3.02% | 1,574,509 | 9.77M |
| 318 | MLTX | MoonLake Immunotherapeutics | 1.29B | -7.47% | 1,249,946 | - |
| 319 | PGNY | Progyny, Inc. | 1.28B | -1.39% | 946,270 | 1.29B |
| 320 | PLSE | Pulse Biosciences, Inc. | 1.27B | -3.01% | 259,828 | 350.00K |
| 321 | CRVS | Corvus Pharmaceuticals, Inc. | 1.27B | -3.64% | 547,225 | - |
| 322 | PHAR | Pharming Group N.V. | 1.22B | 0.65% | 8,324 | 376.13M |
| 323 | DBVT | DBV Technologies S.A. | 1.22B | -3.79% | 181,986 | 5.64M |
| 324 | ZBIO | Zenas BioPharma, Inc. | 1.22B | -3.95% | 384,653 | 10.00M |
| 325 | NVCR | NovoCure Limited | 1.20B | -3.82% | 809,633 | 655.35M |
| 326 | IRMD | IRADIMED CORPORATION | 1.19B | -2.26% | 140,801 | 83.81M |
| 327 | NNNN | Anbio Biotechnology | 1.19B | 0.93% | 10,029 | 8.65M |
| 328 | EYPT | EyePoint, Inc. | 1.18B | -0.28% | 742,028 | 31.37M |
| 329 | MPLT | MapLight Therapeutics, Inc. | 1.18B | -9.11% | 436,599 | - |
| 330 | USPH | U.S. Physical Therapy, Inc. | 1.16B | -0.69% | 111,588 | 773.34M |
| 331 | COLL | Collegium Pharmaceutical, Inc. | 1.15B | 0.62% | 508,039 | 780.57M |
| 332 | ALVO | Alvotech | 1.13B | 0.56% | 174,302 | 588.90M |
| 333 | AVBP | ArriVent BioPharma, Inc. | 1.13B | -6.57% | 337,620 | - |
| 334 | INNV | InnovAge Holding Corp. | 1.11B | -3.42% | 258,188 | 915.37M |
| 335 | CNMD | CONMED Corporation | 1.11B | -0.51% | 248,998 | 1.37B |
| 336 | INBX | Inhibrx Biosciences, Inc. | 1.10B | -0.63% | 315,440 | 1.30M |
| 337 | ABCL | AbCellera Biologics Inc. | 1.07B | 2.91% | 2,409,495 | 75.13M |
| 338 | PNTG | The Pennant Group, Inc. | 1.07B | -3.13% | 141,835 | 947.71M |
| 339 | GERN | Geron Corporation | 1.07B | -5.11% | 16,565,452 | 183.88M |
| 340 | URGN | UroGen Pharma Ltd. | 1.05B | 5.07% | 1,067,911 | 109.79M |
| 341 | BFLY | Butterfly Network, Inc. | 1.05B | -0.96% | 2,281,045 | 97.61M |
| 342 | KMTS | Kestra Medical Technologies, Ltd. | 1.04B | -7.17% | 153,723 | 83.72M |
| 343 | SEPN | Septerna, Inc. | 1.04B | -7.01% | 629,068 | 45.95M |
| 344 | AZTA | Azenta, Inc. | 1.02B | -1.99% | 554,119 | 595.03M |
| 345 | ORIC | ORIC Pharmaceuticals, Inc. | 1.02B | -2.22% | 2,103,875 | - |
| 346 | IVA | Inventiva S.A. | 1.01B | -4.36% | 728,288 | 9.31M |
| 347 | CLOV | Clover Health Investments, Corp. | 1.01B | 1.05% | 4,795,620 | 1.92B |
| 348 | XERS | Xeris Biopharma Holdings, Inc. | 1.01B | -2.66% | 942,078 | 291.85M |
| 349 | PHAT | Phathom Pharmaceuticals, Inc. | 1.00B | -0.08% | 1,441,312 | 175.11M |
| 350 | NEO | NeoGenomics, Inc. | 1.00B | -3.15% | 1,864,599 | 727.33M |
| 351 | KALV | KalVista Pharmaceuticals, Inc. | 993.20M | -2.81% | 629,973 | 73.62M |
| 352 | CRON | Cronos Group Inc. | 981.40M | 1.18% | 538,626 | 146.59M |
| 353 | GHRS | GH Research PLC | 975.10M | 2.95% | 123,286 | - |
| 354 | PCRX | Pacira BioSciences, Inc. | 963.25M | -0.13% | 249,050 | 726.41M |
| 355 | QURE | uniQure N.V. | 961.70M | -5.64% | 3,282,729 | 16.10M |
| 356 | BLFS | BioLife Solutions, Inc. | 953.44M | -3.61% | 346,336 | 96.21M |
| 357 | CTMX | CytomX Therapeutics, Inc. | 949.02M | 3.54% | 3,199,349 | 76.20M |
| 358 | EVO | Evotec SE | 945.19M | 0.38% | 53,894 | 925.65M |
| 359 | QDEL | QuidelOrtho Corporation | 942.93M | -2.12% | 2,498,464 | 2.73B |
| 360 | ANNX | Annexon, Inc. | 938.77M | -4.72% | 2,145,828 | - |
| 361 | AKTS | Aktis Oncology, Inc. | 933.06M | -4.47% | 263,903 | 6.50M |
| 362 | CMPX | Compass Therapeutics, Inc. | 931.05M | -5.14% | 3,158,300 | 850.00K |
| 363 | AMPH | Amphastar Pharmaceuticals, Inc. | 924.19M | -2.40% | 354,446 | 719.89M |
| 364 | TDOC | Teladoc Health, Inc. | 920.20M | -2.86% | 3,346,090 | 2.53B |
| 365 | EVMN | Evommune, Inc. | 918.83M | -10.96% | 357,455 | 13.00M |
| 366 | XNCR | Xencor, Inc. | 910.87M | -0.88% | 530,478 | 125.58M |
| 367 | JANX | Janux Therapeutics, Inc. | 908.22M | 2.75% | 957,407 | 10.00M |
| 368 | LMRI | Lumexa Imaging Holdings, Inc. | 895.74M | 0.22% | 518,361 | 1.02B |
| 369 | JBIO | Jade Biosciences, Inc. | 882.27M | -1.87% | 654,462 | - |
| 370 | OPK | OPKO Health, Inc. | 880.52M | -0.85% | 1,479,601 | 606.88M |
| 371 | CGEM | Cullinan Therapeutics, Inc. | 880.05M | -4.40% | 388,330 | - |
| 372 | TALK | Talkspace, Inc. | 863.78M | - | 1,332,239 | 228.87M |
| 373 | SSII | SS Innovations International, Inc. | 859.74M | -4.87% | 34,663 | 42.48M |
| 374 | FTRE | Fortrea Holdings Inc. | 858.33M | -2.24% | 591,893 | 2.72B |
| 375 | INMD | InMode Ltd. | 857.24M | -1.17% | 1,192,287 | 370.50M |
| 376 | SLS | SELLAS Life Sciences Group, Inc. | 854.81M | -5.74% | 3,964,916 | - |
| 377 | CERT | Certara, Inc. | 850.95M | 2.59% | 4,089,494 | 418.84M |
| 378 | TBPH | Theravance Biopharma, Inc. | 841.91M | -1.21% | 361,592 | 107.46M |
| 379 | SDGR | Schrödinger, Inc. | 839.39M | -0.87% | 1,123,276 | 255.87M |
| 380 | VOR | Vor Biopharma Inc. | 838.25M | -0.83% | 525,911 | - |
| 381 | OMER | Omeros Corporation | 827.24M | -3.53% | 970,357 | - |
| 382 | SANA | Sana Biotechnology, Inc. | 824.62M | -0.96% | 1,380,042 | - |
| 383 | CDNA | CareDx, Inc. | 822.02M | -3.83% | 784,084 | 379.81M |
| 384 | DRUG | Bright Minds Biosciences Inc. | 818.66M | -2.75% | 159,256 | - |
| 385 | ABUS | Arbutus Biopharma Corporation | 811.23M | -3.49% | 2,674,263 | 14.08M |
| 386 | SPRY | ARS Pharmaceuticals, Inc. | 799.34M | -2.66% | 722,348 | 84.28M |
| 387 | MNKD | MannKind Corporation | 793.61M | 0.39% | 3,084,436 | 348.97M |
| 388 | MRVI | Maravai LifeSciences Holdings, Inc. | 789.20M | -1.29% | 983,615 | 185.74M |
| 389 | SLDB | Solid Biosciences Inc. | 789.10M | -0.99% | 647,589 | - |
| 390 | IART | Integra LifeSciences Holdings Corporation | 771.58M | 0.71% | 486,204 | 1.64B |
| 391 | KURA | Kura Oncology, Inc. | 765.82M | -2.03% | 880,088 | 67.48M |
| 392 | RLMD | Relmada Therapeutics, Inc. | 764.64M | -4.20% | 1,764,086 | - |
| 393 | TLRY | Tilray Brands, Inc. | 763.61M | -2.23% | 1,828,631 | 858.28M |
| 394 | BVS | Bioventus Inc. | 753.38M | -0.44% | 326,720 | 568.09M |
| 395 | GDRX | GoodRx Holdings, Inc. | 750.24M | 1.39% | 2,136,980 | 796.85M |
| 396 | DSGN | Design Therapeutics, Inc. | 749.93M | -2.64% | 193,932 | - |
| 397 | MGTX | MeiraGTx Holdings plc | 730.57M | -3.96% | 518,060 | 81.39M |
| 398 | LXRX | Lexicon Pharmaceuticals, Inc. | 728.73M | -2.27% | 1,367,759 | 49.80M |
| 399 | ANRO | Alto Neuroscience, Inc. | 727.72M | 1.70% | 193,407 | - |
| 400 | TENX | Tenax Therapeutics, Inc. | 725.58M | -3.58% | 198,101 | - |
| 401 | ETON | Eton Pharmaceuticals, Inc. | 719.22M | -2.73% | 399,868 | 79.95M |
| 402 | BIOA | BioAge Labs, Inc. | 718.51M | -8.99% | 294,234 | 9.00M |
| 403 | CMPS | COMPASS Pathways plc | 712.95M | -0.90% | 1,307,001 | - |
| 404 | EHAB | Enhabit, Inc. | 709.11M | -0.07% | 537,938 | 1.06B |
| 405 | NUTX | Nutex Health Inc. | 704.15M | -4.40% | 126,293 | 875.26M |
| 406 | SGP | SpyGlass Pharma, Inc. | 693.60M | -2.21% | 82,392 | - |
| 407 | ARVN | Arvinas, Inc. | 692.06M | -3.13% | 490,193 | 262.60M |
| 408 | AMN | AMN Healthcare Services, Inc. | 690.79M | -3.35% | 539,399 | 2.73B |
| 409 | CSTL | Castle Biosciences, Inc. | 687.68M | -1.28% | 443,671 | 344.23M |
| 410 | CBLL | CeriBell, Inc. | 683.19M | -2.26% | 251,587 | 89.06M |
| 411 | GYRE | Gyre Therapeutics, Inc. | 674.81M | 2.07% | 47,005 | 116.59M |
| 412 | OMDA | Omada Health, Inc. | 672.34M | -4.76% | 541,547 | 260.21M |
| 413 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 672.28M | -5.19% | 290,236 | - |
| 414 | ALLO | Allogene Therapeutics, Inc. | 663.08M | -6.53% | 8,398,958 | 22.00K |
| 415 | AVNS | Avanos Medical, Inc. | 659.48M | 0.64% | 312,160 | 701.20M |
| 416 | FBRX | Forte Biosciences, Inc. | 658.58M | 3.51% | 934,669 | - |
| 417 | DRTS | Alpha Tau Medical Ltd. | 641.59M | -0.82% | 126,123 | - |
| 418 | PSNL | Personalis, Inc. | 630.16M | -1.15% | 1,425,064 | 69.65M |
| 419 | LBRX | LB Pharmaceuticals Inc | 615.78M | -7.42% | 590,872 | - |
| 420 | PRME | Prime Medicine, Inc. | 607.38M | -2.28% | 1,688,113 | 4.63M |
| 421 | CBIO | Crescent Biopharma, Inc. | 603.50M | -4.87% | 154,596 | 10.84M |
| 422 | OCGN | Ocugen, Inc. | 594.70M | -5.88% | 6,490,096 | 4.41M |
| 423 | IRWD | Ironwood Pharmaceuticals, Inc. | 591.90M | 0.83% | 1,221,831 | 296.15M |
| 424 | PROK | ProKidney Corp. | 588.74M | 2.63% | 1,750,730 | 893.00K |
| 425 | HSTM | HealthStream, Inc. | 583.60M | -0.15% | 264,073 | 304.06M |
| 426 | CTKB | Cytek Biosciences, Inc. | 582.33M | -1.95% | 480,863 | 201.49M |
| 427 | BWAY | BrainsWay Ltd. | 578.31M | -2.66% | 104,710 | 52.23M |
| 428 | TECX | Tectonic Therapeutic, Inc. | 576.82M | -1.27% | 98,722 | - |
| 429 | MDXG | MiMedx Group, Inc. | 574.95M | -3.97% | 966,154 | 418.63M |
| 430 | CRMD | CorMedix Inc. | 572.32M | -1.63% | 636,732 | 311.71M |
| 431 | UPB | Upstream Bio, Inc. | 570.87M | 0.67% | 733,120 | 2.85M |
| 432 | SIBN | SI-BONE, Inc. | 567.08M | -6.21% | 1,015,179 | 200.93M |
| 433 | PRTA | Prothena Corporation plc | 565.25M | -0.76% | 319,029 | 9.68M |
| 434 | ACRS | Aclaris Therapeutics, Inc. | 561.54M | -0.98% | 617,360 | 7.83M |
| 435 | ESPR | Esperion Therapeutics, Inc. | 557.28M | -0.46% | 10,590,411 | 403.14M |
| 436 | ZVRA | Zevra Therapeutics, Inc. | 556.00M | -2.47% | 690,827 | 106.47M |
| 437 | VALN | Valneva SE | 545.59M | 0.49% | 13,504 | 205.07M |
| 438 | KYTX | Kyverna Therapeutics, Inc. | 541.07M | -6.58% | 694,818 | - |
| 439 | RIGL | Rigel Pharmaceuticals, Inc. | 539.42M | -4.29% | 782,384 | 294.28M |
| 440 | ZURA | Zura Bio Limited | 536.08M | 0.89% | 500,372 | - |
| 441 | TCMD | Tactile Systems Technology, Inc. | 533.04M | -2.21% | 187,065 | 329.52M |
| 442 | EMBC | Embecta Corp. | 524.10M | -0.23% | 486,239 | 1.08B |
| 443 | AVR | Anteris Technologies Global Corp. | 523.01M | 3.09% | 520,577 | 1.91M |
| 444 | LYEL | Lyell Immunopharma, Inc. | 522.32M | -6.12% | 108,297 | 36.00K |
| 445 | AGMB | AgomAb Therapeutics NV | 513.69M | 3.23% | 144,482 | - |
| 446 | CATX | Perspective Therapeutics, Inc. | 509.28M | -0.45% | 498,371 | 884.00K |
| 447 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 5.42M |
| 448 | LRMR | Larimar Therapeutics, Inc. | 503.83M | -4.72% | 1,898,790 | - |
| 449 | FULC | Fulcrum Therapeutics, Inc. | 502.83M | -4.55% | 1,054,782 | 80.00M |
| 450 | FDMT | 4D Molecular Therapeutics, Inc. | 500.82M | -0.30% | 900,753 | 85.21M |
| 451 | AQST | Aquestive Therapeutics, Inc. | 497.94M | -2.16% | 995,602 | 44.55M |
| 452 | IVVD | Invivyd, Inc. | 497.73M | -1.12% | 16,684,859 | 53.43M |
| 453 | OFIX | Orthofix Medical Inc. | 496.99M | -0.32% | 186,798 | 822.31M |
| 454 | STTK | Shattuck Labs, Inc. | 495.22M | -6.49% | 471,950 | 1.00M |
| 455 | KMDA | Kamada Ltd. | 492.69M | -0.24% | 29,892 | 180.46M |
| 456 | IMMX | Immix Biopharma, Inc. | 490.89M | -5.03% | 399,412 | - |
| 457 | PHR | Phreesia, Inc. | 489.75M | -0.37% | 2,623,034 | 480.59M |
| 458 | EIKN | Eikon Therapeutics, Inc. | 487.25M | -0.11% | 706,087 | - |
| 459 | TRDA | Entrada Therapeutics, Inc. | 486.00M | -3.91% | 213,004 | 25.42M |
| 460 | ENGN | enGene Holdings Inc. | 482.32M | -0.96% | 95,288 | - |
| 461 | CTNM | Contineum Therapeutics, Inc. | 480.51M | 0.31% | 154,316 | - |
| 462 | NPCE | NeuroPace, Inc. | 480.09M | -2.66% | 123,174 | 99.99M |
| 463 | ADCT | ADC Therapeutics SA | 475.15M | -0.53% | 644,124 | 81.36M |
| 464 | ZNTL | Zentalis Pharmaceuticals, Inc. | 468.85M | 49.55% | 46,332,589 | 26.87M |
| 465 | VREX | Varex Imaging Corporation | 468.66M | 2.01% | 175,163 | 854.40M |
| 466 | VSTM | Verastem, Inc. | 466.40M | -5.01% | 1,600,868 | 30.91M |
| 467 | ABSI | Absci Corporation | 456.00M | 1.02% | 3,851,848 | 2.80M |
| 468 | RGNX | REGENXBIO Inc. | 454.23M | -1.79% | 479,220 | 170.44M |
| 469 | VTVT | vTv Therapeutics Inc. | 453.69M | -1.98% | 38,637 | 17.00K |
| 470 | AVIR | Atea Pharmaceuticals, Inc. | 451.74M | -2.91% | 271,320 | - |
| 471 | ASMB | Assembly Biosciences, Inc. | 450.82M | -4.79% | 138,898 | 72.30M |
| 472 | LXEO | Lexeo Therapeutics, Inc. | 443.04M | -7.00% | 706,418 | - |
| 473 | YDES | YD Bio Limited | 440.20M | 8.30% | 9,099 | 510.36K |
| 474 | XOMA | XOMA Royalty Corporation | 437.78M | 0.08% | 84,863 | 52.15M |
| 475 | AURA | Aura Biosciences, Inc. | 436.22M | 0.29% | 223,970 | - |
| 476 | AUNA | Auna S.A. | 435.20M | -1.67% | 135,413 | 1.30B |
| 477 | STRO | Sutro Biopharma, Inc. | 428.43M | -3.36% | 202,122 | 102.48M |
| 478 | VNDA | Vanda Pharmaceuticals Inc. | 426.76M | -1.50% | 854,484 | 216.11M |
| 479 | EPRX | Eupraxia Pharmaceuticals Inc. | 423.45M | -3.11% | 63,679 | - |
| 480 | CYH | Community Health Systems, Inc. | 421.67M | - | 971,979 | 12.49B |
| 481 | ALT | Altimmune, Inc. | 421.54M | -4.14% | 1,936,609 | 41.00K |
| 482 | FLGT | Fulgent Genetics, Inc. | 416.23M | -3.93% | 538,662 | 322.67M |
| 483 | ANL | Adlai Nortye Ltd. | 411.81M | -7.00% | 377,440 | 5.40M |
| 484 | EBS | Emergent BioSolutions Inc. | 411.09M | -5.80% | 595,984 | 742.90M |
| 485 | ENTA | Enanta Pharmaceuticals, Inc. | 409.46M | 1.15% | 227,552 | 66.98M |
| 486 | ANGO | AngioDynamics, Inc. | 408.48M | -2.87% | 300,219 | 313.73M |
| 487 | ARMP | Armata Pharmaceuticals, Inc. | 407.36M | -3.56% | 17,787 | 4.90M |
| 488 | MYGN | Myriad Genetics, Inc. | 406.76M | -2.03% | 1,060,614 | 824.50M |
| 489 | CGC | Canopy Growth Corporation | 404.86M | -3.67% | 11,004,274 | 203.04M |
| 490 | PACB | Pacific Biosciences of California, Inc. | 404.68M | -0.74% | 3,593,229 | 160.01M |
| 491 | IPSC | Century Therapeutics, Inc. | 404.38M | -0.44% | 910,557 | 109.16M |
| 492 | KIDS | OrthoPediatrics Corp. | 403.70M | 0.19% | 147,115 | 236.35M |
| 493 | CLYM | Climb Bio, Inc. | 401.73M | 4.47% | 827,963 | - |
| 494 | PRTC | PureTech Health plc | 398.08M | 0.36% | 4,485 | 6.39M |
| 495 | AUTL | Autolus Therapeutics plc | 396.55M | 1.36% | 1,519,558 | 75.39M |
| 496 | PBYI | Puma Biotechnology, Inc. | 395.82M | -0.26% | 317,251 | 228.37M |
| 497 | BBNX | Beta Bionics, Inc. | 393.23M | -8.00% | 2,007,517 | 100.25M |
| 498 | REPL | Replimune Group, Inc. | 393.05M | -19.46% | 8,192,375 | - |
| 499 | BNTC | Benitec Biopharma Inc. | 391.19M | 3.72% | 144,466 | - |
| 500 | IRD | Opus Genetics, Inc. | 381.36M | -2.55% | 869,916 | 14.20M |